JPS59122470A - Preparation of quinoline-3-carboxylic acid derivative - Google Patents

Preparation of quinoline-3-carboxylic acid derivative

Info

Publication number
JPS59122470A
JPS59122470A JP23368482A JP23368482A JPS59122470A JP S59122470 A JPS59122470 A JP S59122470A JP 23368482 A JP23368482 A JP 23368482A JP 23368482 A JP23368482 A JP 23368482A JP S59122470 A JPS59122470 A JP S59122470A
Authority
JP
Japan
Prior art keywords
compound
carboxylic acid
ethyl
formula
dihydroquinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP23368482A
Other languages
Japanese (ja)
Other versions
JPH0240066B2 (en
Inventor
Toshihiro Fujiwara
藤原 敏洋
Hideaki Tsurumi
鶴見 秀昭
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Priority to JP23368482A priority Critical patent/JPS59122470A/en
Publication of JPS59122470A publication Critical patent/JPS59122470A/en
Publication of JPH0240066B2 publication Critical patent/JPH0240066B2/ja
Granted legal-status Critical Current

Links

Abstract

PURPOSE:To prepare the titled compound useful as an antibacterial agent, in high yield and purity, by reacting a compound such as 7-chloro-1-ethyl-6-fluoro-4- oxo-1,4-dihydroquinoline-3-carboxylic acid BF2-chelate, etc. with a piperazine compound. CONSTITUTION:The objective quinoline-3-carboxylic acid derivative of formula III[R1 is alkyl; R2 is H or alkyl; X1 is halogen; preferably R1 is ethyl, R2 is H and X1 is F, e.g. 1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydroquinoline-3- carboxylic acid etc.] is prepared by reacting the compound of formula I (X2 is halogen) with the piperazine compound of formula II (e.g. piperazine anhydride). The starting compound of formula I can be obtained by reacting the compound of formula IV with boron trifluoride, boron trifluoride complex, or fluoroboric acid. EFFECT:High selectivity and efficiency.

Description

【発明の詳細な説明】 本発明はキノリン−3−カルボン酸誘導体の製造法に関
する。更に詳しくは1本発明は式(式中、 R1は低級
アルキル基を、 xl及びkは同じ又は異なるハロゲン
原子を意味する。)で表わされる化合物を式 (式中、R2は水素原子又は低級アルキル基を意味する
。)で表わされる化合物と反応させて式%式% () ×1 (式中、R1,R12及び海は前記に同じである。)で
表わされる化合物を製する方法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing quinoline-3-carboxylic acid derivatives. More specifically, the present invention provides a compound represented by the formula (wherein R1 represents a lower alkyl group, and xl and k represent the same or different halogen atoms), a compound represented by the formula (wherein R2 represents a hydrogen atom or a lower alkyl The present invention relates to a method for producing a compound represented by the formula % formula % ( ) × 1 (wherein R1, R12 and sea are the same as above) by reacting the compound with a compound represented by the formula %.

化合物(1)は医療上有用な抗菌物質として知られてお
り(特開昭58−141286号及び特開昭54−13
8582号公報参照)、その製造法としては前記公報及
び特開昭57−62259号公報に記載されている製造
法がある。
Compound (1) is known as a medically useful antibacterial substance (JP-A-58-141286 and JP-A-54-13).
(Refer to Japanese Patent No. 8582), and its manufacturing method includes the manufacturing method described in the aforementioned publication and Japanese Patent Application Laid-open No. 57-62259.

しかし、これらの製造法を用いた場合、ピペラジン類(
1)がキノリン誘導体の6位に置換した式 (式中、R1,R2及びx2は前記に同じであり、 R
3は水素原子又は低級アルキル基を意味する。)で表わ
される化合物が少なからず副生ずるという欠点がある。
However, when these production methods are used, piperazines (
1) is substituted at the 6-position of a quinoline derivative (wherein R1, R2 and x2 are the same as above, R
3 means a hydrogen atom or a lower alkyl group. ) has the disadvantage that a considerable amount of the compound represented by is produced as a by-product.

前記特開昭57−62259号公報には化合物(酌のよ
うな副生物は全く見られないとの記載があるが9本発明
者らが本公報記載の製造法を追試したところ、得られた
生成物中には約25%の副生物(ト)が存在することが
判明した。
Although the above-mentioned Japanese Patent Application Laid-open No. 57-62259 states that no by-products such as cup are observed at all, the inventors of the present invention reexamined the production method described in this publication and obtained Approximately 25% by-products were found to be present in the product.

本発明者らは従来法のかかる欠点を克服すべく鋭意検討
した結果1本発明を完成した。
The present inventors have completed the present invention as a result of intensive studies to overcome these drawbacks of conventional methods.

即ち1本発明は化合物(1)をピペラジン類(If)と
反応させることからなる化合物(1)の製造法である。
That is, the present invention is a method for producing compound (1), which comprises reacting compound (1) with piperazine (If).

原料として用いられる化合物(I)は次の方法に(式中
* X++ X2及び昭ま前記に同じであり、R4は水
素原子又は低級アルキル基を意味する。)即ち、化合物
(V)に三7ツ化ホウ素、三7.化ホfy素fa体又は
ホウフッ化水素酸を反応させることにより原料化合物(
I)を得ることができる。
Compound (I) used as a raw material is prepared by the following method (in the formula *X++ is the same as above, and R4 means a hydrogen atom or a lower alkyl group). Boron tsunide, 37. The raw material compound (
I) can be obtained.

三フッ化ホウ素錯体としては各種のものが使用可能であ
るが、三7.化ホウ素のテトラヒドロフラン錯体及びジ
エチルエーテル錯体などが具体例としてあげられる。ま
たホウフッ化水素酸は通常水溶液として使用される。
Various types of boron trifluoride complexes can be used, including 37. Specific examples include tetrahydrofuran complexes and diethyl ether complexes of boron chloride. Further, fluoroboric acid is usually used as an aqueous solution.

三77化ホウ素、三フッ化ホウ素錯体又はホウフッ化水
素酸の使用量は化合物(V) 1モルに対し1モル以上
存在すれば良いが通常1〜50モルの範囲が使用される
The amount of boron tri77ide, boron trifluoride complex or fluoroboric acid to be used may be 1 mol or more per 1 mol of compound (V), but it is usually in the range of 1 to 50 mol.

溶媒としてはアセトンなどのケトン系のもの。The solvent is a ketone type such as acetone.

ジエチルエーテルなどのエーテル系のもの、ベンゼン又
はトルエン等各種のものが使用でき。
Various types of ethers such as diethyl ether, benzene or toluene can be used.

また三フッ化ホウ素錯体もしくはホウフッ化水素酸を溶
媒と兼ねさせても良い。溶媒の使用量は通常化合物(V
)1部に対し2−50部の範囲が好適である。
Further, a boron trifluoride complex or fluoroboric acid may also be used as a solvent. The amount of solvent used is usually determined by the amount of the compound (V
) is preferably in the range of 2-50 parts.

反応温度は室温でもよいが1反応時間の短縮ということ
から更に高温でもよく9通常室温〜150°Cの温度範
囲が好適である。
The reaction temperature may be at room temperature, but may be at a higher temperature in order to shorten the reaction time.9 Usually, a temperature range of room temperature to 150°C is preferred.

生成した化合物(I)は反応液を冷却すれば結晶として
析出するので、これを濾取することにより容易に得るこ
とができる。
The produced compound (I) precipitates as crystals when the reaction solution is cooled, and can be easily obtained by filtering the crystals.

このようにして得られた原料化合物(1)を用いて本発
明方法を行うには、化合物(I)に対し一乃 5− 全数倍モルの化合物(1)を無溶媒で又は溶媒中。
In order to carry out the method of the present invention using the raw material compound (1) thus obtained, compound (1) is added in an amount of 1 to 5 times the total number of moles of compound (I) without a solvent or in a solvent.

脱酸剤の存在下反応させればよい。The reaction may be carried out in the presence of a deoxidizing agent.

脱酸剤は、副生ずるハロゲン水素及びBF2−キレート
分解物の除去に使用され、その具体例としてはトリエチ
ルアミン、トリブチルアミンもしくはピリジンの如き有
機三級アミン又は炭酸カリウムの如き無機塩基があげら
れるが、を委吻徊看過剰の化合物(I[)が脱酸剤とし
て働くこともある。脱酸剤の使用量は化合物(I)1モ
ルに対し通常1〜8モルが好ましい。
A deoxidizer is used to remove by-produced halogen hydrogen and BF2-chelate decomposition products, and specific examples include organic tertiary amines such as triethylamine, tributylamine, or pyridine, or inorganic bases such as potassium carbonate. Excess amount of compound (I[) may act as a deoxidizing agent. The amount of the deoxidizing agent used is usually preferably 1 to 8 mol per 1 mol of compound (I).

また、この反応ではBF2−キレート部分がカルボキシ
ル基となるためにプロトンが必要とされるが、これは過
剰の原料又は混在する微量の水分等により供給されるこ
とが考えられる。
Further, in this reaction, a proton is required because the BF2-chelate moiety becomes a carboxyl group, but it is thought that this is supplied by an excess raw material or a small amount of water present.

溶媒としては、ジメチルスルホキシド、ジメチルホルム
アミドもしくはジメチルアセトアミド等の非プロトン性
極性溶媒、アセトンもしくはメチルエチルケトン等のケ
トン系溶媒、ジエ 6− メタノールモジくハエタノール等のアルコール系溶媒等
が使用できる。溶媒の使用量は化合物(1) 1部に対
し2〜80部(重散比)の範囲で使用される。
As the solvent, aprotic polar solvents such as dimethyl sulfoxide, dimethylformamide or dimethylacetamide, ketone solvents such as acetone or methyl ethyl ketone, alcohol solvents such as ethanol, etc. can be used. The amount of solvent to be used is in the range of 2 to 80 parts (polydispersity ratio) per 1 part of compound (1).

反応は室温〜200°Cの範囲で2〜lO時間行なえば
よい。
The reaction may be carried out at room temperature to 200°C for 2 to 10 hours.

尚、該反応においては溶媒の種類を選択し、脱酸剤の使
用量1反応温度及び反応時間等を調節することにより、
ピペラジン類(I)の置換反応のく式中* ”I+ R
2及びxlは前記に同じである。)で表わされる中間体
を得ることも可能である。
In addition, in this reaction, by selecting the type of solvent, adjusting the amount of deoxidizing agent used, reaction temperature, reaction time, etc.
In the substitution reaction of piperazine (I) * “I+ R
2 and xl are the same as above. ) It is also possible to obtain intermediates of the form

例えば、ジメチルスルホキシド中室温で反応を行なった
場合、中間体側)が収率よく得られる。
For example, when the reaction is carried out in dimethyl sulfoxide at room temperature, the intermediate) can be obtained in good yield.

中間体側)は1反応液を冷却するか2反応液に水等の難
溶性の溶媒を加えることにより析出するので、これを濾
取することにより容易に単離できる。
Since the intermediate (intermediate side) is precipitated by cooling the first reaction solution or adding a poorly soluble solvent such as water to the second reaction solution, it can be easily isolated by filtering it.

中間体(9)は単離してもよいが、単離せずに次のキレ
ート分解反応を行なっても良い。
Intermediate (9) may be isolated, but may also be subjected to the next chelate decomposition reaction without being isolated.

中間体(W)より目的化合物(1)を得るには、中間体
(v)を脱酸剤の存在下無溶媒もしくは溶媒中プロトン
性の化合物と処理すればよい。
In order to obtain the target compound (1) from the intermediate (W), the intermediate (v) may be treated with a protic compound in the presence of a deoxidizer or without a solvent.

プロトン性化合物としては水、アルコール類。Protic compounds include water and alcohols.

チオール類、−級アミン類、二級アミン類又は無機水酸
化物等が使用される。
Thiols, -class amines, secondary amines, inorganic hydroxides, etc. are used.

脱酸剤としては水酸化ナトリウム、炭酸ナトリウムもし
くは炭酸水素ナトリウム等の無機塩基又は−級アミン、
二級アミンもしくは三級アミン等の有機塩基があげられ
、中間体CM)に対し等モル以上使用される。
As a deoxidizing agent, an inorganic base such as sodium hydroxide, sodium carbonate or sodium bicarbonate, or a -class amine;
Organic bases such as secondary amines or tertiary amines are mentioned, and are used in an amount equal to or more than the same mole relative to the intermediate CM).

溶媒としては非プロトン性極性溶媒、ケトン系溶媒、ア
ルコール系溶媒、エステル系溶媒又はエーテル系溶媒等
があげられるが特にアルコール系溶媒、エステル系溶媒
又はエーテル系溶媒が好ましい。
Examples of the solvent include aprotic polar solvents, ketone solvents, alcohol solvents, ester solvents, and ether solvents, with alcohol solvents, ester solvents, and ether solvents being particularly preferred.

反応は、室温〜150℃までの範囲で行なえばよい。The reaction may be carried out at a temperature ranging from room temperature to 150°C.

生成した化合物(1)は1反応液を中和するが又は冷却
すれば結晶として析出するので、これを濾取することに
より容易に得ることができる。
The produced compound (1) precipitates as crystals when the reaction solution is neutralized or cooled, and can be easily obtained by filtering the crystals.

以上のように本発明方法により選択的、高収率、高純度
及び能率よく、医療上有用な抗菌剤である化合物偵)を
得ることができ9本発明は工業的に有利な製造法である
As described above, by the method of the present invention, it is possible to selectively, in high yield, with high purity, and efficiently obtain a compound which is a medically useful antibacterial agent.9 The present invention is an industrially advantageous production method. .

次に参考例及び実施例を説明する。Next, reference examples and examples will be explained.

参考例1 7−クロロ−1−エチル−6−フルオロ−4−オキソ−
1,4−ジヒドロキノリン−3−カルボン酸エチルエス
テル2.939及びホウ7ツ化水素酸42%水溶液15
m/の混液を80〜90’Cで3時間加熱する。冷後析
出晶を濾取し、水及びメタノールで洗浄し、?−クロロ
ー1−エチル−6−フルオロ−4−オキソ−1,4−ジ
ヒドロキノリン−8−カルボン酸−BFz−キレート8
.10g(収率99%)をえた。融点aoo”(:以上
Reference example 1 7-chloro-1-ethyl-6-fluoro-4-oxo-
1,4-dihydroquinoline-3-carboxylic acid ethyl ester 2.939 and 42% aqueous borosilicate 15
Heat the m/mixture at 80-90'C for 3 hours. After cooling, the precipitated crystals were filtered and washed with water and methanol. -chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-8-carboxylic acid-BFz-chelate 8
.. 10 g (yield 99%) was obtained. Melting point aoo" (: or higher.

−〇 − 元素分析値 Os 2 )18N OsB CI F3
として計算値 G 45.40.  Hg、54.  
N  4.41実測値 C45,21,H2,61,N
  4.42’H−NMR(DMSO−as、IS:T
MS)δ(ppm):1.49 (:3 H,t、 −
CH5・)4.95 (2H,Q、 −CH2−)8.
58 (IH,d、 J−10H2,5位−〇H−)8
.88 (IH,d、 J−6)12.8位−CH−)
9.64 (IH,s、 2位−〇H−)Mass :
 817 (M” ) 参考例2 7−クロロ−1−エチル−6−フルオロ−4−オキソ−
1,4−ジヒドロキノリン−8−カルボン酸エチルエス
テル5,859.三フフ化ホウ素テトラヒドロ7ラン錯
体12.7り及びダウサム21−の混液を120〜13
0”Cで2時間加熱する。今後、析出晶を濾取し、クロ
ロポルム及びメタノールで洗浄し、7−クロ*−1−エ
チル−6−フルオロ−4−オキソ−1,4−ジヒドロキ
ノリン−3−カルボン酸−BF2−キレー)4.679
(収率82%〕をえた。融点300°C以上。
-〇- Elemental analysis value Os2)18N OsB CI F3
Calculated value as G 45.40. Hg, 54.
N 4.41 actual measurement value C45, 21, H2, 61, N
4.42'H-NMR (DMSO-as, IS:T
MS) δ (ppm): 1.49 (:3 H, t, -
CH5・)4.95 (2H,Q, -CH2-)8.
58 (IH, d, J-10H2, 5th position-〇H-)8
.. 88 (IH, d, J-6) 12.8-position -CH-)
9.64 (IH,s, 2nd place-〇H-)Mass:
817 (M”) Reference example 2 7-chloro-1-ethyl-6-fluoro-4-oxo-
1,4-dihydroquinoline-8-carboxylic acid ethyl ester 5,859. A mixture of boron trifluoride tetrahydro 7 run complex 12.7 and Dowsum 21 was added to 120 to 13
Heat at 0"C for 2 hours. Then, the precipitated crystals are collected by filtration, washed with chloroporm and methanol, and 7-chloro*-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3 -Carboxylic acid-BF2-Kyle) 4.679
(Yield: 82%). Melting point: 300°C or higher.

参考例3 7−クロロ−1−エチル−6−フルオロ−4−オキソ−
1,4−ジヒドロキノリン−3−カルボン114.80
9及びホウフッ化水素酸42%水溶液21−の混液を8
0〜90’Cで2時間加熱する。冷後、析出晶を濾取し
、水及びメタノールで洗浄し、7−クロロ−1−エチル
−6−フルオロ−4−オキソ−1,4−ジヒドロキノリ
ン−8−カルボン酸−BF2−キレ−)5.109(収
率100%)をえた。融点800°C以上。
Reference example 3 7-chloro-1-ethyl-6-fluoro-4-oxo-
1,4-dihydroquinoline-3-carvone 114.80
9 and a 42% aqueous solution of borohydrofluoric acid 21-
Heat at 0-90'C for 2 hours. After cooling, the precipitated crystals were collected by filtration and washed with water and methanol to give 7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-8-carboxylic acid-BF2-chelate). 5.109 (yield 100%) was obtained. Melting point over 800°C.

参考例4 7−クロロ−1−エチル−6−フルオロ−4オキソ−1
,4−ジヒドロキノリン−8−カルボン酸1.669及
び三ツ、化ホウ素テトラヒドロ7ラン錯体17m/の混
液を80〜90°Cで8時間加熱する。冷後、析出晶を
濾取し、クロロホルムで洗浄し、7−クロロ−1−エチ
ル−6−フルオロ−4−オキソ−1,4−ジヒドロキノ
リンー3−カルボン酸−BF2−キレート1.68g(
収率86%)をえた。融点aoo’c以上。
Reference example 4 7-chloro-1-ethyl-6-fluoro-4oxo-1
, 1.669 m/4-dihydroquinoline-8-carboxylic acid and 17 m/m of tri-borohydride tetrahydro-7-rane complex is heated at 80-90°C for 8 hours. After cooling, the precipitated crystals were collected by filtration and washed with chloroform to give 1.68 g of 7-chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid-BF2-chelate (
A yield of 86% was obtained. Melting point aoo'c or higher.

′実施例1 7−クロロ−1−エチル−6−フルオロ−4−オキソ−
1,4−ジヒドロキノリン−8−カルボン酸−BF2−
キレート1.000g、無水ピペラジン0.814g及
びジメチルスルホキシド5−の混液を室温下6時間攪拌
する。反応液はいったん溶液となるが1時間程経過する
と結晶が析出する。反応後、冷水5−を加え結晶を濾取
し、水洗し、90°Cで5時間減圧乾燥し、1−エチル
−6−フルオロ−4−オキソ−7−(l−ピペラジニル
)−1,4−ジヒドロキノリン−3−カルボン酸−BF
2−キレート1.1189(収率96%)をえた。融点
253〜255℃。
'Example 1 7-chloro-1-ethyl-6-fluoro-4-oxo-
1,4-dihydroquinoline-8-carboxylic acid-BF2-
A mixture of 1.000 g of chelate, 0.814 g of anhydrous piperazine, and 5-dimethyl sulfoxide is stirred at room temperature for 6 hours. The reaction solution becomes a solution once, but crystals precipitate out after about 1 hour. After the reaction, cold water was added and the crystals were collected by filtration, washed with water, and dried under reduced pressure at 90°C for 5 hours to give 1-ethyl-6-fluoro-4-oxo-7-(l-piperazinyl)-1,4. -dihydroquinoline-3-carboxylic acid-BF
1.1189 2-chelate (yield 96%) was obtained. Melting point: 253-255°C.

元素分析値 016H17N3038F3として計算値
 G  52.84.  H4,67、N  11.4
5実測値 0 52.46.  H4,56,N  1
1.82’H−NMR(DMSO−ds、Is:TM8
)δ(ppm):1.49 (8H,t、 −aH3) 4−87 (2J q+  CH20H3)7.85 
(LH,d、 J−8Hz、 8位−CH−)8.09
 (LH,d、 J−14H2,5位−〇H−)9.0
4 (IH,8,2位−〇H−)Mass  :  8
67 (M”) 上記化合物1.1189及び6%水酸化す) IJウム
水溶液8.9−の混液を1時間還流した。反応液を酢酸
で中和して、 pH7〜7.5に調整する。今後、析出
する結晶を濾取し、水及びメタノールで洗浄する。これ
をクロロホルムとエタノールの混合溶液から再結晶し、
90°Cで5時M減圧乾燥し、1−エチル−6−フルオ
ロ−4−オキソ−7−(1−ピペラジニル)−1,4−
ジヒドロキノリン−3−カルボン10.904g(収率
93%ンをえた。融点221〜222℃。
Elemental analysis value Calculated value as 016H17N3038F3 G 52.84. H4, 67, N 11.4
5 Actual value 0 52.46. H4, 56, N 1
1.82'H-NMR (DMSO-ds, Is:TM8
) δ (ppm): 1.49 (8H, t, -aH3) 4-87 (2J q+ CH20H3) 7.85
(LH, d, J-8Hz, 8th position -CH-)8.09
(LH, d, J-14H2, 5th position-〇H-)9.0
4 (IH, 8, 2nd position-〇H-)Mass: 8
67 (M") A mixture of the above compound 1.1189 and 6% hydroxylated IJium aqueous solution 8.9- was refluxed for 1 hour. The reaction solution was neutralized with acetic acid and adjusted to pH 7 to 7.5. .Then, the precipitated crystals are collected by filtration and washed with water and methanol.This is recrystallized from a mixed solution of chloroform and ethanol.
Dry at 90°C for 5 hours under reduced pressure to obtain 1-ethyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-
10.904 g of dihydroquinoline-3-carvone (yield 93%) was obtained. Melting point: 221-222°C.

元素分析値 G)sHIB03N3Fとして計算値 C
60,18,H5,68,N  13.16実測値 C
60,15,H5,74,N  18.27本品は前記
公報(特開昭5a−0+i2s/致した。
Elemental analysis value G) Calculated value as sHIB03N3F C
60,18,H5,68,N 13.16 Actual value C
60, 15, H5, 74, N 18.27 This product was published in the above-mentioned publication (JP-A-5A-0+I2S/).

実施例2 7−クロロ−1−エチル−6−フルオロ−4−オキソ−
1,4−ジヒドロキノリン−8−カルボン酸−BF2−
キレート1.ooog、無水ピペラジン0.814g及
びジメチルスルホキシド5a/(7)混液を100℃で
3時間加熱する。次いで6%水酸化す) IJウム水溶
液8−を加え。
Example 2 7-chloro-1-ethyl-6-fluoro-4-oxo-
1,4-dihydroquinoline-8-carboxylic acid-BF2-
Chelate 1. ooog, 0.814 g of anhydrous piperazine and dimethyl sulfoxide 5a/(7) mixture are heated at 100° C. for 3 hours. Then, a 6% aqueous solution of hydroxide was added.

120°Cで2時間加熱した。反応液に酢酸を加え、p
H7〜7.5に調整し、析出する結晶を濾取し、水及び
メタノールで洗浄する。クロロホルムとエタノールの混
合溶液で再結晶し、90″Cで5時間減圧乾燥し、1−
エチル−6−フルオロ−4−オキソ−7−(l−ヒ°ペ
ラジニル)−1,4−ジヒドロキノリン−3−カルボン
酸0.8619(収率86%ンをえた。融点220〜2
21℃。
Heated at 120°C for 2 hours. Add acetic acid to the reaction solution,
The temperature is adjusted to 7 to 7.5, and the precipitated crystals are collected by filtration and washed with water and methanol. The 1-
Ethyl-6-fluoro-4-oxo-7-(l-hyperazinyl)-1,4-dihydroquinoline-3-carboxylic acid 0.8619% (yield 86%) was obtained. Melting point 220-2
21℃.

実施例3 7−クロロ−1−エチル−6−フルオロ−4−オキソ−
1,4−ジヒドロキノリン−8−カルボン酸−BF2−
キレート567■、無水ピペラジン630■及びジメチ
ルスルホキシド2.8−の混液を110℃で8時間加熱
した。反応液に水10−を加え、さらに酢酸を加え、 
pH7,5に調整する。冷後、析出晶を濾取し水洗する
Example 3 7-chloro-1-ethyl-6-fluoro-4-oxo-
1,4-dihydroquinoline-8-carboxylic acid-BF2-
A mixture of 567 ml of chelate, 630 ml of anhydrous piperazine and 2.8 ml of dimethyl sulfoxide was heated at 110 DEG C. for 8 hours. Add water 10- to the reaction solution, further add acetic acid,
Adjust the pH to 7.5. After cooling, the precipitated crystals are collected by filtration and washed with water.

これをクロロホルムとエタノールの混合溶液で再結晶し
、90’Cで5時間減圧乾燥し、■−エチルー6−フル
オロー4−オキソ−7−(1−ス や ピプラシル)−1,4−ジヒドロキノリン−8−カルボ
ン酸419■(収率73%)をえた。融点220〜22
1″C0 実施例4 7−クロロ−1−エチル−6−フルオロ−4−オキソ−
1,4−ジヒドロキノリン−8−カルホン酸−BF2−
キレ−)72fl19,4−メチルビペラジン6871
L9及びジメチルスルホキシド8.6−の混液を110
℃で3時間加熱した。反15一 応液に6%水酸化す) IJウム水溶液5.8dを加え
、110℃で2時間加熱した。反応終了後。
This was recrystallized from a mixed solution of chloroform and ethanol, dried under reduced pressure at 90'C for 5 hours, and 1-ethyl-6-fluoro-4-oxo-7-(1-su or pipracil)-1,4-dihydroquinoline- 419 ml of 8-carboxylic acid (yield 73%) was obtained. Melting point 220-22
1″C0 Example 4 7-chloro-1-ethyl-6-fluoro-4-oxo-
1,4-dihydroquinoline-8-carphonic acid-BF2-
72fl19,4-methylbiperazine 6871
A mixture of L9 and dimethyl sulfoxide 8.6-110
Heated at ℃ for 3 hours. 5.8 d of an aqueous IJ solution (6% hydroxide) was added to the anti-15 solution and heated at 110° C. for 2 hours. After the reaction is complete.

酢酸を反応液に加え、pH7〜7.5に調整する。Add acetic acid to the reaction solution and adjust the pH to 7-7.5.

冷後、析出する結晶を濾取する。メタノールで洗浄し、
90°Cで5詩間減圧乾燥し、l−エチル−6−フルオ
ロ−7−(4−メチル−1−ピペラジニル)−4−オキ
ソ−1,4−ジヒドロキノリン−8−カルボン酸653
■(収率86%)をえた。融点268〜270℃。
After cooling, precipitated crystals are collected by filtration. Wash with methanol,
Dry under reduced pressure at 90°C for 5 cycles to obtain l-ethyl-6-fluoro-7-(4-methyl-1-piperazinyl)-4-oxo-1,4-dihydroquinoline-8-carboxylic acid 653
(yield 86%) was obtained. Melting point: 268-270°C.

元素分析値 017H2ON303Fとして計算値 G
  61.25.  H6,05,N  12.60実
測値 0 61.10.  H5,91,N  12.
2716−
Elemental analysis value Calculated value as 017H2ON303F G
61.25. H6,05,N 12.60 Actual value 0 61.10. H5,91,N 12.
2716-

Claims (1)

【特許請求の範囲】 ■)式 (式中、 xl及び乃は同じ又は異なるハロゲン原子を
+ ”Iは低級アルキル基を意味する。)で表わされる
化合物を1式 (式中、R2は水素原子又は低級アルキル基を意味する
。)で表わされるピペラジン類と反応させることを特徴
とする式 (式中+ xI+ Fll及び−は前記に同じである。 )1− で表わされる化合物の製造法 2、特許請求の範囲第1項においてR1がエチル基、 
R2が水素原子、Xlがフッ素原子である化金物の製造
[Scope of Claims] ■) A compound represented by the formula (wherein xl and 0 are the same or different halogen atoms + ``I means a lower alkyl group) (wherein, R2 is a hydrogen atom) or a lower alkyl group) (in the formula, + In claim 1, R1 is an ethyl group,
A method for producing a chemical compound in which R2 is a hydrogen atom and Xl is a fluorine atom
JP23368482A 1982-12-27 1982-12-27 Preparation of quinoline-3-carboxylic acid derivative Granted JPS59122470A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP23368482A JPS59122470A (en) 1982-12-27 1982-12-27 Preparation of quinoline-3-carboxylic acid derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP23368482A JPS59122470A (en) 1982-12-27 1982-12-27 Preparation of quinoline-3-carboxylic acid derivative

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP13400487A Division JPS62294689A (en) 1987-05-29 1987-05-29 Quinoline-3-carboxylic acid derivative

Publications (2)

Publication Number Publication Date
JPS59122470A true JPS59122470A (en) 1984-07-14
JPH0240066B2 JPH0240066B2 (en) 1990-09-10

Family

ID=16958915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP23368482A Granted JPS59122470A (en) 1982-12-27 1982-12-27 Preparation of quinoline-3-carboxylic acid derivative

Country Status (1)

Country Link
JP (1) JPS59122470A (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003595A1 (en) 1985-12-09 1987-06-18 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Norfloxacin intermediate
WO1987003587A1 (en) 1985-12-09 1987-06-18 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Process for the preparation of quinoline carboxylic acids
WO1988007998A1 (en) * 1987-04-08 1988-10-20 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Quinoline carboxylic acid boric acid anhydrides and process for the preparation thereof
JPS6419069A (en) * 1987-07-14 1989-01-23 Dainippon Pharmaceutical Co Production of polyhalogenoquinoline derivative
GR880100231A (en) * 1987-04-08 1989-01-31 Chinoin Gyogyszer Es Vegyeszet Preparation method of quinoline carboxylic acids
JPH01503301A (en) * 1987-04-08 1989-11-09 キノイン ギオギスゼル エス ベギエスゼチ テルメケク ギヤラ アール.ティー Method for producing quinoline carboxylic acid
JPH02500366A (en) * 1987-06-24 1990-02-08 キノイン ギオギスゼル エス ベギエスゼチ テルメケク ギヤラ アールティー. Method for producing quinoline carboxylic acid derivatives
JPH02501839A (en) * 1986-12-04 1990-06-21 アウディ アクチェンゲゼルシャフト Exhaust gas system for internal combustion engines with two cylinder supports
FR2640974A1 (en) * 1988-12-22 1990-06-29 Chinoin Gyogyszer Es Vegyeszet
WO1993002055A1 (en) * 1991-07-16 1993-02-04 Chugai Seiyaku Kabushiki Kaisha Process for producing quinolonecarboxylic acid derivative
US5284950A (en) * 1985-12-09 1994-02-08 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Process for the preparation of quinoline carboxyolic acids
US5294712A (en) * 1985-12-09 1994-03-15 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Process for the preparation of quinoline carboxylic acids
US5869661A (en) * 1991-07-16 1999-02-09 Chugai Seiyaku Kabushiki Kaisha Method of producing a quinolonecarboxylic acid derivative
US7361780B2 (en) 2003-01-31 2008-04-22 Mitsubishi Rayon Co., Ltd. Apparatus for producing hydroxyalkyl(meth)acrylate and process for producing the same

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
JPS54138582A (en) * 1978-04-19 1979-10-27 Kyorin Seiyaku Kk Substituted quinolinecarboxylic acid
JPS5547658A (en) * 1978-09-29 1980-04-04 Kyorin Pharmaceut Co Ltd Substituted quinolinecarboxylic acid derivative
JPS5762259A (en) * 1980-09-05 1982-04-15 Kyorin Pharmaceut Co Ltd Preparation of substituted quinolinecarboxylic acid derivative

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
JPS54138582A (en) * 1978-04-19 1979-10-27 Kyorin Seiyaku Kk Substituted quinolinecarboxylic acid
JPS5547658A (en) * 1978-09-29 1980-04-04 Kyorin Pharmaceut Co Ltd Substituted quinolinecarboxylic acid derivative
JPS5762259A (en) * 1980-09-05 1982-04-15 Kyorin Pharmaceut Co Ltd Preparation of substituted quinolinecarboxylic acid derivative

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0351889A1 (en) 1985-12-09 1990-01-24 CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. Process for the preparation of a quinoline carboxylic acid
WO1987003587A1 (en) 1985-12-09 1987-06-18 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Process for the preparation of quinoline carboxylic acids
US5294712A (en) * 1985-12-09 1994-03-15 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Process for the preparation of quinoline carboxylic acids
US5284950A (en) * 1985-12-09 1994-02-08 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. Process for the preparation of quinoline carboxyolic acids
WO1987003595A1 (en) 1985-12-09 1987-06-18 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Norfloxacin intermediate
JPH02501839A (en) * 1986-12-04 1990-06-21 アウディ アクチェンゲゼルシャフト Exhaust gas system for internal combustion engines with two cylinder supports
GR880100231A (en) * 1987-04-08 1989-01-31 Chinoin Gyogyszer Es Vegyeszet Preparation method of quinoline carboxylic acids
JPH01503301A (en) * 1987-04-08 1989-11-09 キノイン ギオギスゼル エス ベギエスゼチ テルメケク ギヤラ アール.ティー Method for producing quinoline carboxylic acid
JPH01503300A (en) * 1987-04-08 1989-11-09 キノイン ギオギスゼル エス ベギエスゼチ テルメケク ギヤラ アール.ティー Quinoline carboxylic acid boric anhydride and its production method
GR880100232A (en) * 1987-04-08 1989-01-31 Chinoin Gyogyszer Es Vegyeszet Quinoline carboxylic acid boric acid anhydrides and process for the preparation therefor
AU612648B2 (en) * 1987-04-08 1991-07-18 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Process for the preparation of quinoline carboxylic acids
AU613035B2 (en) * 1987-04-08 1991-07-25 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Quinoline carboxylic acid boric acid anhydrides and process for the preparation thereof
WO1988007998A1 (en) * 1987-04-08 1988-10-20 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Quinoline carboxylic acid boric acid anhydrides and process for the preparation thereof
JPH02500366A (en) * 1987-06-24 1990-02-08 キノイン ギオギスゼル エス ベギエスゼチ テルメケク ギヤラ アールティー. Method for producing quinoline carboxylic acid derivatives
JPS6419069A (en) * 1987-07-14 1989-01-23 Dainippon Pharmaceutical Co Production of polyhalogenoquinoline derivative
FR2640974A1 (en) * 1988-12-22 1990-06-29 Chinoin Gyogyszer Es Vegyeszet
WO1993002055A1 (en) * 1991-07-16 1993-02-04 Chugai Seiyaku Kabushiki Kaisha Process for producing quinolonecarboxylic acid derivative
US5869661A (en) * 1991-07-16 1999-02-09 Chugai Seiyaku Kabushiki Kaisha Method of producing a quinolonecarboxylic acid derivative
US7361780B2 (en) 2003-01-31 2008-04-22 Mitsubishi Rayon Co., Ltd. Apparatus for producing hydroxyalkyl(meth)acrylate and process for producing the same

Also Published As

Publication number Publication date
JPH0240066B2 (en) 1990-09-10

Similar Documents

Publication Publication Date Title
JP6061158B2 (en) Synthesis intermediate of 6- (7-((1-aminocyclopropyl) methoxy) -6-methoxyquinolin-4-yloxy) -N-methyl-1-naphthamide, or a pharmaceutically acceptable salt thereof, and its use
JP3963490B2 (en) Method for producing one-pot of 3-quinolonecarboxylic acid derivative
JPS59122470A (en) Preparation of quinoline-3-carboxylic acid derivative
IL182439A (en) Intermediates useful for the preparation of aripiprazole and methods for the preparation of the intermediates and aripiprazole
JPS63316757A (en) 3-amino-2-substituted benzoylacrylic acid derivative
NO147838B (en) INTERMEDIATE FOR USE IN PREPARATION OF THE HYPOTENSIVE AGENT 2- (4- (2-FUROYL) PIPERAZIN-1-YL) -4-AMINO-6,7-DIMETOXYKINAZOLINE
JP2015524426A (en) Novel production method of 1-oxacephalosporin derivative
JPH05112588A (en) Process for manufacturing acrylaminomethanesulfonic acid
US4182880A (en) 1,8-Naphthyridine compounds and process for preparing the same
JPH02289563A (en) Improved process for producing ortho-carboxypyridyl- and ortho-carboxyquinolylimidazolinones
JPS63264439A (en) Production of 3,5,6-trifluoro-4-hydroxyphthalic acid
JPS62294689A (en) Quinoline-3-carboxylic acid derivative
CS261250B2 (en) Method of 1-methylaminoquinolinecarboxyl acid's and its derivatives production
RU2127270C1 (en) Method of synthesis of 1-substituted-6-fluoro-4-oxo-7-(1- -piperazinyl)-1,4-dihydroquinoline-3-carboxylic acid, 1-substituted-6-fluoro-4-oxo-7-(4-substituted-1-piperazinyl)- -1,4-dihydroquinoline-3-carboxylate-boron-diacetate and a method of its synthesis
JPH0148910B2 (en)
KR900004878B1 (en) Process for preparing of quinoline derivatives
JPS6011707B2 (en) 1-Carboxyalkylcarbamoyl-5-fluorouracil derivative and method for producing the same
JPS6130571A (en) Preparation of 3-phenyl-4-cyanopyrrole
JPS603382B2 (en) Novel production method for isoindoline derivatives
JPH05163279A (en) Production of oxazopyrroloquinoline ester
JPS5951534B2 (en) Method for producing 2-amino-3-hydroxypyridine derivative
JPS61238781A (en) Novel intermediate and manufacture
JP2001002645A (en) Production of 2,6-diamino-3,5-difluoropyridine
JP2010502607A (en) Methods for the synthesis and synthesis of (3-alkyl-5-piperidin-1-yl-3,3a-dihydro-pyrazolo [1,5-a] pyrimidin-7-yl) -amino derivatives and intermediates Intermediate
WO1995021828A1 (en) Process for producing hexahydropyridazine and hexahydropyridazine-1,2-dicarboxylate derivative